Geode Capital Management LLC Raises Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Geode Capital Management LLC raised its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 3.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,426,129 shares of the real estate investment trust's stock after purchasing an additional 192,465 shares during the period. Geode Capital Management LLC owned 2.38% of Omega Healthcare Investors worth $261,589,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of OHI. State Street Corp boosted its holdings in Omega Healthcare Investors by 0.9% in the third quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust's stock valued at $502,228,000 after acquiring an additional 114,085 shares during the last quarter. Assetmark Inc. lifted its position in shares of Omega Healthcare Investors by 1.7% in the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock worth $48,492,000 after purchasing an additional 19,542 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of Omega Healthcare Investors by 120.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust's stock valued at $9,212,000 after purchasing an additional 123,836 shares during the last quarter. Daiwa Securities Group Inc. increased its position in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock worth $160,739,000 after buying an additional 3,003,845 shares during the period. Finally, Caxton Associates LP bought a new position in Omega Healthcare Investors during the second quarter worth $1,652,000. 65.25% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Omega Healthcare Investors Stock Up 1.1 %

NYSE OHI traded up $0.41 during mid-day trading on Friday, hitting $39.21. The company's stock had a trading volume of 1,655,830 shares, compared to its average volume of 1,687,985. The firm has a market capitalization of $10.58 billion, a price-to-earnings ratio of 28.83, a PEG ratio of 1.21 and a beta of 0.98. The company's 50 day simple moving average is $40.38 and its 200 day simple moving average is $37.97. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.83%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's payout ratio is presently 197.06%.

Analyst Ratings Changes

A number of analysts have commented on the stock. BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target on the stock in a research report on Monday, December 9th. Mizuho upped their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a "neutral" rating in a research report on Thursday, December 5th. Truist Financial lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. BNP Paribas upgraded Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Finally, Scotiabank raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research report on Monday, August 26th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of "Moderate Buy" and a consensus price target of $40.18.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.